Exploratory Impact of iCARE Nigeria, a Combined mHealth and Peer Navigation Intervention, on Depressive Symptoms and Substance Use Among Youth Living With HIV in Nigeria: Single-Arm Trial
JMIR Formative Research · 2025
DOI: 10.2196/71141 ↗Kurz gefasst
Klinische Studie in der Zeitschrift JMIR Formative Research, 2025. Verfasst von Olusegun Ayomikun Ogunmola und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Child and Adolescent Mental Health, College of Medicine, University of Ibadan, Ibadan, Nigeria. Hauptthemen laut MEDLINE: HIV Infections, Depression, Peer Group, Substance-Related Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, FIC NIH HHS, NCATS NIH HHS.
Themen: Depression
Abstract (Originalsprache)
Background
Mental health problems are a barrier to the well-being of youth living with HIV. Many youth living with HIV in Nigeria face peculiar biopsychosocial vulnerabilities that predispose them to mental health problems including depression and substance use. In addition to improving treatment outcomes like medication adherence and linkage to care, peer engagement has shown some promise in improving the social and emotional well-being of this population. Mobile health (mHealth) interventions like SMS text messaging medication reminders may also contribute to better outcomes in youth living with HIV. Emerging evidence suggests that combination interventions may be more effective than single interventions in improving key HIV testing and treatment outcomes among youth in Nigeria.
Objective
This study aims to explore the impact of Intensive Combination Approach to Rollback the Epidemic in Nigerian Adolescents (iCARE Nigeria) study—an mHealth and peer navigation intervention primarily aimed at medication adherence and viral suppression—on depressive symptoms and substance use among youth living with HIV in Nigeria.
Methods
A single-arm clinical trial was conducted at the Infectious Disease Institute, College of Medicine, University of Ibadan, Nigeria— primarily to improve medication adherence and viral suppression among youth living with HIV attending its HIV clinic. The intervention combined peer navigation and daily, 2-way, text message medication reminders delivered over a period of 48 weeks. Participants were screened at baseline and follow-up visits (24 and 48 weeks) for depression and substance use using standardized measures. Paired t tests and McNemar tests were used to investigate the change in depressive symptoms and the change in the proportion of participants reporting substance use over time, respectively.
Results
All 40 enrolled participants (n=20, 50% male; mean age 19.9 y, SD 2.5 y) completed baseline and follow-up visits at week 24, while 37 (92.5%) participants completed the week 48 visit. Compared with baseline, there were significantly fewer self-reported depressive symptoms observed at 48 weeks (mean 2.89 vs 2.08; t 36 =2.04, 95% CI 0.006‐1.615) but not at 24 weeks (mean 2.89 vs 2.62; t 36 =0.47, 95% CI –0.74 to 1.44). There were fewer self-reports of substance use at weeks 24 and 48 when compared to baseline, but these were not statistically significant (odds ratio [OR] ∞, 95% CI 0.189-∞ and OR 3.0, 95% CI 0.24‐157.49, respectively).
Conclusions
These findings suggest a statistically significant reduction in depressive symptoms among youth living with HIV over the 48-week intervention period that may be due to the iCARE Nigeria intervention. However, given limitations such as low levels of depressive symptoms at baseline, small sample size, and the lack of a control group, future studies such as the randomized stepped wedge evaluation of the iCARE intervention are needed to provide better insights into these exploratory findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Child and Adolescent Mental Health, College of Medicine, University of Ibadan, Ibadan, Nigeria.
- Infectious Disease Institute, College of Medicine, University of Ibadan, Ibadan, Nigeria.
- Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
- Division of Adolescent Medicine, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, IL, United States.
- Department of Family Medicine, University College Hospital, Ibadan, Ibadan, Nigeria.
- Department of Psychiatry, College of Medicine, University of Ibadan, University College Hospital premises, Queen Elizabeth II Road, Ibadan, 200212, Nigeria, 234 8132243158.
ORCID-Profile: Olusegun Ayomikun Ogunmola, Rita Frinue Tamambang, Kehinde Kuti, Lisa M Kuhns, Olutosin Awolude, Adedotun Adetunji, Bibilola Oladeji, Oladayo Olaleye, Adeola Mary Oyerinde, Robert Garofalo, Babafemi Taiwo, Olayinka Olusola Omigbodun
Förderung
- NICHD NIH HHS
- FIC NIH HHS
- NCATS NIH HHS
Zitieren
APA
Ogunmola, O. A., Tamambang, R. F., Kuti, K., Kuhns, L. M., Awolude, O., Adetunji, A., Oladeji, B., Olaleye, O., Oyerinde, A. M., Garofalo, R., Taiwo, B., & Omigbodun, O. O. (2025). Exploratory Impact of iCARE Nigeria, a Combined mHealth and Peer Navigation Intervention, on Depressive Symptoms and Substance Use Among Youth Living With HIV in Nigeria: Single-Arm Trial. JMIR Formative Research. https://doi.org/10.2196/71141
Vancouver
Ogunmola OA, Tamambang RF, Kuti K, Kuhns LM, Awolude O, Adetunji A, et al. Exploratory Impact of iCARE Nigeria, a Combined mHealth and Peer Navigation Intervention, on Depressive Symptoms and Substance Use Among Youth Living With HIV in Nigeria: Single-Arm Trial. JMIR Formative Research. 2025. doi:10.2196/71141
BibTeX
@article{Ogunmola2025,
author = {Ogunmola, Olusegun Ayomikun and Tamambang, Rita Frinue and Kuti, Kehinde and Kuhns, Lisa M and Awolude, Olutosin and Adetunji, Adedotun and Oladeji, Bibilola and Olaleye, Oladayo and Oyerinde, Adeola Mary and Garofalo, Robert and Taiwo, Babafemi and Omigbodun, Olayinka Olusola},
title = {Exploratory Impact of iCARE Nigeria, a Combined mHealth and Peer Navigation Intervention, on Depressive Symptoms and Substance Use Among Youth Living With HIV in Nigeria: Single-Arm Trial},
journal = {JMIR Formative Research},
year = {2025},
doi = {10.2196/71141}
}
EUVIMED